MARKET

SNN

SNN

Smith & Nephew
NYSE
31.08
+0.38
+1.24%
After Hours: 31.08 0 0.00% 16:10 07/13 EDT
OPEN
30.83
PREV CLOSE
30.70
HIGH
31.27
LOW
30.76
VOLUME
1.67M
TURNOVER
--
52 WEEK HIGH
37.90
52 WEEK LOW
28.56
MARKET CAP
13.13B
P/E (TTM)
21.71
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SNN last week (0706-0710)?
Weekly Report · 15h ago
Smith & Nephew price target lowered to 1,550 GBp from 1,600 GBp at Citi
TipRanks · 3d ago
Solving A Lackluster Growth Outlook Should Be Solventum's Next Priority
Seeking Alpha · 3d ago
Citi Remains a Buy on Smith & Nephew (SN)
TipRanks · 3d ago
New German expert consensus provides first risk-based recommendations for sNPWT use in closed surgical incisions
Barchart · 5d ago
New German expert consensus highlights role for NPWT in mitigating the economic impact of postoperative wound complications
Barchart · 5d ago
Health Rounds: Newer style hip implant significantly cuts dislocation risk
Reuters · 6d ago
Analyst Maintains Buy Rating While Cutting Price Target to £13.40 on Near-Term Knee Segment Pressures but Backing Mid-Term Growth Story
TipRanks · 6d ago
More
About SNN
Smith & Nephew plc is a portfolio medical technology company. The Company is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, which includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilize severe fractures and correct bone deformities; Sports Medicine & ENT businesses offer advanced products and instruments used to repair or remove soft tissue, and Advanced Wound Management provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds. The Company also owns Integrity Orthopaedics, which is an early stage commercial developer of Tendon Seam, an innovative and disruptive biomechanical RCR system.

Webull offers Smith & Nephew PLC (ADR) stock information, including NYSE: SNN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNN stock methods without spending real money on the virtual paper trading platform.